Cargando…
Sleep-Related Breathing Disorders in Multiple Sclerosis: Prevalence, Features and Associated Factors
BACKGROUND: Multiple sclerosis (MS) represents a risk factor for sleep disorders, but there are conflicting results about the prevalence and severity of sleep-related breathing disorders (SRBD) in MS. Most available data come from self-administered questionnaires. OBJECTIVE: To conduct a polysomnogr...
Autores principales: | Sparasci, Davide, Fanfulla, Francesco, Ferri, Raffaele, Aricò, Debora, Distefano, Daniela, Pravatà, Emanuele, Heinzer, Raphael, Haba-Rubio, José, Berger, Mathieu, Riccitelli, Gianna Carla, Gobbi, Claudio, Zecca, Chiara, Manconi, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035459/ https://www.ncbi.nlm.nih.gov/pubmed/35478718 http://dx.doi.org/10.2147/NSS.S359858 |
Ejemplares similares
-
Fatigue, sleepiness and depression in multiple sclerosis: defining the overlaps for a better phenotyping
por: Sparasci, Davide, et al.
Publicado: (2022) -
Contribution of sleep disturbances to fatigue in multiple sclerosis: a prospective study using clinical and polysomnographic parameters
por: Riccitelli, Gianna C., et al.
Publicado: (2021) -
Migraine in Multiple Sclerosis Patients Affects Functional Connectivity of the Brain Circuitry Involved in Pain Processing
por: Pravatà, Emanuele, et al.
Publicado: (2021) -
Treatment satisfaction, adherence and behavioral assessment in patients de – escalating from natalizumab to interferon beta
por: Zecca, Chiara, et al.
Publicado: (2014) -
Use of glatiramer acetate between 2010–2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients
por: Zecca, Chiara, et al.
Publicado: (2019)